The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Results of Meetings and Transaction Update

24 Jan 2022 12:35

RNS Number : 4062Z
JPMorgan European Invest Tst PLC
24 January 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL.

24 January 2022

JPMorgan European Investment Trust plc

Results of Meetings and Transaction Update

Results of Meetings

The Board of JPMorgan European Investment Trust plc (the "Company") is pleased to announce that the Resolutions proposed at the General Meeting, the Growth Class Meeting and the Income Class Meeting, each held earlier today, were voted on by poll and all were passed.

The full text of all the resolutions can be found in the circular published by the Company on 20 December 2021 (the "Circular") which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and from the Company's website, www.jpmeuropean.co.uk.

A summary of proxy votes received will shortly be available on the Company's website, www.jpmeuropean.co.uk.

Transaction Update

Following the passing of all Resolutions the Company expects shortly to conclude the unification of the Income Shares and Growth Shares into a single class of Ordinary Shares, each having a nominal value of 0.5 pence and a NAV of 100 pence as determined at 5:00 p.m. on 31 January 2022 (the "Calculation Date").

Shareholders are reminded that in order to be on the register by 31 January 2022 (the "Record Date") the last date for trading in the Growth Shares and the Income Shares for normal T+2 settlement is 27 January 2022.

The Company expects to announce the results of the Restructuring and the resulting number of Ordinary Shares on 3 February 2022, with dealings in Ordinary Shares expected to commence at 8:00 a.m. on 4 February 2022 ("Admission").

A new ISIN has been obtained for the Ordinary Shares - GB00BPR9Y246. The Ordinary Shares will also trade under a new ticker, JEGI, and the Company's name will be changed to JPMorgan European Growth & Income plc with effect from Admission.

Terms used and not defined in this announcement shall have the meanings given to them in the Circular.

 

For further information please contact:

 

JPMorgan Funds Limited

Tim Mitchell - 0207 742 8879

Paul Winship - 0207 742 9815

Winterflood Securities Limited

Neil Morgan - 020 3100 0292

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMBKQBNBBKDBDB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.